Custom Antibody Discovery and Assay Design

Custom Monoclonal Antibody Development

Whether searching for a recombinant antibody to identify a new biomarker or looking for a robust antibody that has better performance and sensitivity for diagnostic development, users can increase their chance of success with Abcam.

Abcam’s Unique Offering

1. Precision: The expertise to deliver antibodies that meet or exceed specifications.

With an established track record of creating particular antibodies against an extensive range of protein targets across various research areas, and for a wide range of applications, such as mass spectrometry and IHC, users can depend on Abcam to deliver when it counts.

2. Agility: The confidence to take the antibody from research to clinic.

The IP available on Abcam’s discovery platforms allows users to effortlessly take the same clone they are verifying in their laboratory assays and take it all the way into the clinic.

3. Accuracy: The solutions to accurately screen for the right antibody, at speed.

Abcam has the required experience and tools to design and run bespoke assay cascades to carry out the library screen for users. HTRF, epitope binning, IC50, fluorescence assays, functional and reporter assays, and PK/PD are just a few examples of what Abcam can offer.

4. Flexibility: The skills to support users, wherever they are in their program.

Abcam’s teams have wide industry experience and can work closely with users, thus meeting the latter’s specific requirements. Abcam takes care of everything from designing antigens to supplying GMP/IVD. Alternatively, the company can help with specific parts of the users’ project. On the whole, users can consider Abcam as an extension to their in-house capabilities.

Let’s Get Started

With its skill sets and established multiplatform method, such as the proprietary NGS-Rabbit monoclonal platform, Abcam is confident that it is the best option for users. Users are encouraged to discuss their next custom antibody development project.

About Abcam

Abcam is a global life sciences company providing highly validated antibodies and other binders and assays to the research and clinical communities to help advance the understanding of biology and causes of disease.

Abcam’s mission is to serve life scientists to help them achieve their mission faster by listening to their needs, continuously innovating and improving and by giving them the tools, data and experience they want. Abcam’s ambition is to become the most influential life science company for researchers worldwide.

Sponsored Content Policy: publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: May 15, 2019 at 8:57 AM


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Abcam. (2019, May 15). Custom Antibody Discovery and Assay Design. News-Medical. Retrieved on January 24, 2020 from

  • MLA

    Abcam. "Custom Antibody Discovery and Assay Design". News-Medical. 24 January 2020. <>.

  • Chicago

    Abcam. "Custom Antibody Discovery and Assay Design". News-Medical. (accessed January 24, 2020).

  • Harvard

    Abcam. 2019. Custom Antibody Discovery and Assay Design. News-Medical, viewed 24 January 2020,

Other White Papers by this Supplier